Accelerating new rare disease therapies through collaboration agreement Cambridge, MA, USA & Rostock/Berlin, GERMANY,13 November 2019 – CENTOGENE (Nasdaq: CNTG),commercial-stage company …
Centogene AG Rings The Nasdaq Stock Market Closing Bell in Celebration of its IPO
…
CENTOGENE Announces Proposed Initial Public Offering of Common Shares
October 28, 2019 at 8:53 AM EDT CAMBRIDGE, Mass. and ROSTOCK, Germany, Oct. 28, 2019 (GLOBE NEWSWIRE) -- Centogene B.V. (“Centogene” or the “Company”), a commercial-stage company focused on rare …
CENTOGENE Welcomed Germany’s Chancellor Dr. Angela Merkel
CENTOGENE welcomed Germany’s Chancellor Dr. Angela Merkel on May 23, 2019 to its headquarters together with Manuela Schwesig, Minister-President of Mecklenburg-Vorpommern. The visit focused on …
CENTOGENE announces the appointment of Dr. Flemming Ornskov to the Supervisory Board as Non-Executive Chairman
Rostock/Berlin, Germany, 2 April, 2019 – CENTOGENE announced today that Dr. Flemming Ornskov has been appointed to the Supervisory Board and has been elected Non-Executive Chairman. His appointment …